Evidence map›Paper›PMID 42138642›Full record

ArticleJournal of Alzheimer's disease : JAD2026

(Alzheimer's) dementia in adults with Down syndrome in Germany: Administrative prevalence based on a claims data analysis.

Milena Weitzel, Anke Walendzik, Godwin D Giebel, Pascal Raszke, Jürgen Wasem, Johannes Levin, Georg Nübling, Olivia Wagemann, Elisabeth Wlasich, Johannes Pantel and 5 more

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Milena WeitzelInstitute for Health Care Management and Research, University of Duisburg-Essen, Essen, Germany.ORCID 0009-0008-7947-5290
Anke WalendzikEssen Research Institute for Medical Management, EsFoMed GmbH, Essen, Germany.
Godwin D GiebelInstitute for Health Care Management and Research, University of Duisburg-Essen, Essen, Germany.ORCID 0000-0002-4182-1927
Pascal RaszkeInstitute for Health Care Management and Research, University of Duisburg-Essen, Essen, Germany.
Jürgen WasemInstitute for Health Care Management and Research, University of Duisburg-Essen, Essen, Germany.
Johannes LevinDepartment of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.ORCID 0000-0001-5092-4306
Georg NüblingDepartment of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
Olivia WagemannDepartment of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
Elisabeth WlasichDepartment of Neurology, LMU University Hospital, LMU Munich, Munich, Germany.
Johannes PantelInstitute for General Practice, Goethe University, Frankfurt am Main, Germany.
Valentina A TeskyInstitute for General Practice, Goethe University, Frankfurt am Main, Germany.
Arthur SchallInstitute for General Practice, Goethe University, Frankfurt am Main, Germany.
Thomas RuhnkeAOK Research Institut (WIdO), Berlin, Germany.ORCID 0000-0002-5955-4142
Patrik DrögeAOK Research Institut (WIdO), Berlin, Germany.
Theresa HüerInstitute for Health Care Management and Research, University of Duisburg-Essen, Essen, Germany.ORCID 0009-0008-7628-5707

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BackgroundPeople with Down syndrome (DS) have a significantly increased risk of developing early-onset Alzheimer's disease. For example, a longitudinal study by McCarron et al. (2017) found that 97% of a cohort of 77 DS patients aged 35 years and older developed dementia. Despite this high risk, administrative data on dementia prevalence in this population remain limited.ObjectiveThis study examines whether the diagnosed prevalence is lower than expected based on epidemiological data and explores differences compared to the general population.MethodsA comparative analysis of administrative dementia prevalence (2010-2019) was conducted using claims data for adults with and without DS. Prevalence rates were calculated by age and sex. Chi-square tests were applied to assess significance (p < 0.05), with Cramér's V and Phi as measures of association. Odds ratios were calculated to evaluate group differences.ResultsTotal administrative dementia prevalence was significantly higher in adults with DS (Mean Value (MV) 9.2% ± 1.7% (Standard Deviation (SD))) than those without DS (MV 3.2% ± 0.3% (SD)). Age- and sex-specific analyses also revealed notable differences. For example, in the 56-60 years age group, prevalence was MV 28.7% ± 4.6% (SD) in adults with DS versus MV 0.7% ± 0.1% (SD) in those without DS.ConclusionsAlthough administrative dementia prevalence is higher among adults with DS than those without DS, observed rates appear lower than expected based on existing epidemiological data. This suggests a potential underdiagnosis of dementia in the DS population in Germany.

Indexed as

Alzheimer DiseaseDown SyndromeAdultAgedDementiaFemaleGermanyHumansLongitudinal StudiesMaleMiddle AgedPrevalenceAlzheimer's diseasedementiadiagnosisDown syndromehealth careprevalence

Identifiers

PMID42138642
PMCPMC13291392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.